ALB and neoplasm: Xu and coworkers designed an NO donor-S-nitrosated HSA (HSA–NO) to co-load near-infrared (NIR) light-absorbing agents (IR780) and the chemotherapy drug PTX for GSH and NIR-responsive NO release, which can enhance the tumor vascular permeability at low NO concentrations and directly kill cancer cells at high NO concentrations.